Breast irradiation with brachytherapy: approved techniques and new concepts
- PMID: 17923829
Breast irradiation with brachytherapy: approved techniques and new concepts
Abstract
Among surgery and chemotherapy, radiotherapy has an important role in the treatment of breast cancer patients. But not only external beam radiotherapy (EBRT) treatment is an established method for treatment of breast cancer, also brachytherapy (BT) is an approved method. BT is well known for boost irradiation in combination with EBRT, but new indications as re-irradiation for local recurrences or partial breast irradiation offer new aspects in the field of BT for breast cancer treatment. Because of modern CT based 3-D treatment planning systems and the possibility of intensity modulated brachytherapy (IMBT) has getting more potential. In the future for selected patient's re-irradiation of the breast using IMBT after local relapse and second breast conserving surgery might be an alternative instead of mastectomy. Even partial breast BT following breast conservative operation as a new treatment option is getting more and more interesting and is widely investigated in several studies. Due to the approved techniques and the new indications BT is and will be an attractive alternative and extension in the field of breast cancer treatment. But we need five better ten years results for definite conclusions at least.
Similar articles
-
High-dose-rate (HDR) or pulsed-dose-rate (PDR) perioperative interstitial intensity-modulated brachytherapy (IMBT) for local recurrences of previously irradiated breast or thoracic wall following breast cancer.Strahlenther Onkol. 2006 Feb;182(2):102-7. doi: 10.1007/s00066-006-1496-x. Strahlenther Onkol. 2006. PMID: 16447017
-
Radiotherapy confined to the tumor bed following breast conserving surgery current status, controversies, and future projects.Strahlenther Onkol. 2002 Nov;178(11):597-606. doi: 10.1007/s00066-002-0966-z. Strahlenther Onkol. 2002. PMID: 12426670 Review.
-
Early European experience with the MammoSite radiation therapy system for partial breast brachytherapy following breast conservation operation in low-risk breast cancer.Breast. 2006 Jun;15(3):319-25. doi: 10.1016/j.breast.2006.05.002. Breast. 2006. PMID: 16765284 Clinical Trial.
-
[Brachytherapy boost for breast cancer: what do we know? Where do we go?].Cancer Radiother. 2004 Aug;8(4):248-54. doi: 10.1016/j.canrad.2004.07.002. Cancer Radiother. 2004. PMID: 15450518 Review. French.
-
Partial breast irradiation: revolution or evolution?Cancer Treat Rev. 2004 Nov;30(7):599-607. doi: 10.1016/j.ctrv.2004.06.009. Cancer Treat Rev. 2004. PMID: 15531394 Review.
Cited by
-
In vitro effects of imatinib mesylate on radiosensitivity and chemosensitivity of breast cancer cells.BMC Cancer. 2010 Aug 9;10:412. doi: 10.1186/1471-2407-10-412. BMC Cancer. 2010. PMID: 20691121 Free PMC article.
-
Novel multi‑kinase inhibitor, T03 inhibits Taxol‑resistant breast cancer.Mol Med Rep. 2018 Feb;17(2):2373-2383. doi: 10.3892/mmr.2017.8179. Epub 2017 Nov 28. Mol Med Rep. 2018. PMID: 29207185 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Medical